The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™, a new antibiotic combination developed to treat complicated intra-abdominal infections caused by drug-resistant bacteria. This app...
Subscribe Our Newsletter
“You are my favorite medical source online”
Subscribe to DigimedUpdates for exclusive content and expert insights on all things digital.